In the past, eye care professionals believed that most dry eye was caused by lack of tear production or chronic inflammation on the ocular surface. This incorrect assumption lead doctors to treat some cases of dry eye disease incorrectly, not fully understanding the root cause of the patient’s symptoms. Fortunately, we now know that there are many different causes for dry eye and can now focus on a treatment plan individual to each patient.
One of the leading causes for dry eye disease is Meibomian Gland Dysfunction (MGD). Meibomian glands are located in the eyelids and produce oil which aids in preventing tear evaporation. MGD occurs when the meibomian glands are blocked and normal oil production is altered. This can cause red, irritated eyelids, excess watering or a burning, gritty sensation. Traditional treatment suggestions for MGD only provided minimal relief for these symptoms. At our Ocular Surface Clinic, we gather information for your doctor to identify if MGD is the cause for your dry eye. With the Lipiview® technology, we can image your Meibomian glands and discuss treatment options that would work best for your specific dry eye needs.
The Lipiflow® is the only FDA approved device to treat MGD. This comfortable in-office procedure gently warms the eyelids and massages the eyelids to help open the glands and release trapped oil. Early treatment of MGD is very important to prevent irreversible damage to the eye. Schedule an appointment for the Ocular Surface Clinic to see if you are a good candidate for the Lipiflow®.